PROFOUND MEDICAL CORP (PROF) Stock Cash Flow
NASDAQ:PROF - Nasdaq - CA74319B5027 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -32.34M | -27.82M | -28.57M | -28.67M | -30.70M | |||
| Depreciation Amortization | 794.00K | 936.00K | 1.15M | 1.60M | 1.88M | |||
| Income Taxes - Deferred | N/A | -149.00K | 58.00K | N/A | N/A | |||
| Change In Working Capital | 2.02M | 1.69M | 296.00K | -3.72M | -1.05M | |||
| Interest Paid | N/A | N/A | 669.00K | N/A | N/A | |||
| Taxes Paid | N/A | N/A | 160.00K | N/A | N/A | |||
| Other non cash items | 3.04M | 1.89M | 4.77M | 4.99M | 7.51M | |||
| OPERATING CASH FLOW | -26.64M | -23.45M | -22.30M | -25.80M | -22.36M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -593.00K | |||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | 0.00 | -593.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -2.15M | -2.56M | -1.20M | -356.00K | -386.00K | |||
| Stock Issued/Repurchased | 39.21M | 62.15M | 2.67M | 263.00K | 6.43M | |||
| Other Financing Activity | -3.04M | -4.89M | 0.00 | 7.12M | -99.00K | |||
| FINANCING CASH FLOW | 34.02M | 54.70M | 1.46M | 7.03M | 5.95M | |||
| Exchange Rate Effect | -2.13M | -2.54M | 529.00K | -1.87M | 244.00K | |||
| CHANGE IN CASH | 5.25M | 28.70M | -20.30M | -20.64M | -16.76M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -26.64M | -23.45M | -22.30M | -25.80M | -22.36M | |||
| Capital Expenditure | N/A | N/A | N/A | 0.00 | -593.00K | |||
| FREE CASH FLOW | -26.64M | -23.45M | -22.30M | -25.80M | -22.95M | |||
All data in USD